WAYNE, Pa., April 1, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet"), a specialty pharmaceutical company developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and other indications, announced today that it was added to the Russell 3000®, Russell 2000® and Russell Global Indexes as part of Russell Investments' first quarter IPO additions. The change to the indexes took effect at the close of the U.S. markets yesterday Monday, March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
